Maajid highlights the troubling history of pharmaceutical companies, emphasizing the need to question their motives, especially during emergencies. He draws attention to the staggering impact of the opioid crisis, which claimed more lives than the AIDS crisis, and discusses the significant fines imposed on major companies like GlaxoSmithKline and Pfizer. This critical examination urges listeners to reconsider the assumption that these corporations always act in the public's best interest.
